ࡱ> jli{` 6bjbjFF .X,,.<<<<<xDBBBBBBBB$KChE:BC C C :BOB!!!C B!C B!!R>A r<Y ?BeB0B?{Fi {F<A{FAtZ"@!b4:B:B!BC C C C << GIIntroduction to GI and Bilirubin Normal Metabolism of Bilirubin Bilirubin is a breakdown product of hemoglobin in RBCs. The formation of bilirubin occurs in reticuloendothelial cells, primarily the spleen and the liver. In the first reaction, heme oxygenase converts heme to biliverdin. In the second reaction, biliverdin reductase converts biliverdin to bilirubin. This bilirubin is unconjugated, indirect, and insoluble in water, so it is not found in the urine. Unconjugated bilirubin bound to albumin is transported to the liver, where it is taken up by hepatocytes via a process that partly involves carrier-mediated membrane transport. In the liver, bilirubin is conjugated to glucuronic acid by bilirubin glucuronosyltransferase. This bilirubin is conjugated, direct, and soluble in water. Any bilirubin found in the urine is conjugated bilirubin and implies liver dysfunction. It is then actively transported into bile channels by an ATP-pump. Conjugated bilirubin drains into the duodenum and passes through the proximal small bowel. It is not absorbed by the intestinal mucosa. In the distal ileum and colon, it is converted back to unconjugated bilirubin by normal gut bacteria. 80-90% of this product is excreted in the feces, known as stercobilinogen, which gives feces its brown color. 10-20% is passively absorbed, enters the portal venous blood, and is re-excreted by the liver. A small amount escapes hepatic uptake, filters across the glomerulus and is excreted in the urine. Jaundice Jaundice, or icterus, is yellowish discoloration of tissue resulting from deposition of bilirubin in the presence of serum hyperbilirubinemia. May result from 1) overproduction of bilirubin 2) impaired uptake or impaired conjugation of bilirubin 3) impaired excretion of bilirubin. Normal total bilirubin is between 0.3-1.0. We usually have more indirect bilirubin, which is 0.2-0.8. The direct bilirubin is 0.1-0.3. the urine will contain 0-0.2 of the direct bilirubin. The initial manifestations of jaundice will be seen at levels greater than 2.5. The first symptoms are yellowing of the skin and then yellowing of the sclera. Increase in unconjugated bilirubin results from overproduction, impaired uptake, or impaired conjugation Increase in conjugated bilirubin results from decreased excretion into the bile ducts or backward leakage of the pigment Evaluation of the Jaundiced Patient The initial steps in evaluating the patient with jaundice are to determine 1) whether the hyperbilirubinemia is predominantly conjugated or unconjugated 2) whether other biochemical liver tests are abnormal History Chemical/medication hepatotoxins or alcohol Parenteral exposures anything outside the GI tract (IV drug use, transfusions, sexual activity, tattoos, intranasal drug use) Travel history endemic areas of hepatitis Contaminated foods HAV, HEV Document the duration of jaundice and presence of any accompanying symptoms arthralgias, myalgias, rash, anorexia, weight loss, abdominal pain, fever, pruritis, and changes in the urine and stool Physical Assess the patients nutritional status albumin levels of at least 3-4 Look for signs of chronic liver disease/cirrhosis spider nevi, palmar erythema, gynecomastia, caput medusa (due to portal HTN), testicular atrophy, JVD, right-sided heart failure, right pleural effusion, or ascites. LAD left supraclavicular node (Virchows node), periumbilical nodule (Sister Mary Josephs nodule) suggests an abdominal malignancy. Document in abdominal exam the size and consistency of the liver and the presence of splenomegaly or ascites. RUQ pain with inspiratory/respiratory arrest is Murphys sign, which is specific for cholecystitis. Etiology of Hyperbilirubinemia Pre-Hepatic Pre-hepatic is an increased production of heme resulting in unconjugated hyperbilirubinemia. Hemolytic disorders normal LFTs Hereditary spherocytosis; sickle cell anemia characterized by periods of decreased O2; G6PD deficiency enzyme produced by the RBC responsible for metabolizing carbohydrates and protects the RBC from oxidizing substances. Patient has episodic and recurrent hemolysis; increased bone marrow production will increase breakdown Acquired hemolytic uremic syndrome, autoimmune hemolysis Hepatic Hepatic is mixed conjugated-unconjugated hyperbilirubinemia. Due to decreased bilirubin uptake and conjugation a) Drug induced decreased hepatic uptake Rifampin Tylenol INH Probenecid b) 3 genetic conditions cause impaired bilirubin conjugation (unconjugated is greater than conjugated) - serum bilirubin concentrations are most often <3mg/dL. Gilberts syndrome is a relatively common condition that affects 3-7% of the population with male predominance. There is mild, unconjugated hyperbilirubinemia with serum levels of about 6mg/dL. High values are associated with stress, fatigue, alcohol use, and reduced caloric intake. Impaired bilirubin conjugation is secondary to reduced bilirubin glucuronosyltransferase activity. Crigler-Najjar Type I is an increase in unconjugated bilirubin from about 20-45mg/dL. It is a rare neonatal condition characterized by severe jaundice (bilirubin >20mg/dL) and neurological impairment due to kernicterus, frequently leading to death in infancy. The major clinical manifestation in children is kernicterus opisthotonos, abnormal posture with severe back rigidity and arching. This is due to complete absence of bilirubin glucuronosyltransferase activity. The patient is totally unable to conjugate, hence bilirubin cannot be excreted. The only life-saving treatment is liver transplant. Crigler-Najjar Type II is when patients live into adulthood with serum bilirubin levels of 6 to 25mg/dL. Mutations in bilirubin glucuronosyltransferase causes reduced but not completely absent activity of the enzyme. Patients are also susceptible to kernicterus. c) Impaired Liver Function Fetal bilirubin is cleared by the placenta and eliminated by the maternal liver. Many hepatic physiologic processes are incompletely developed at birth. Normal bilirubin in the newborn is 1-12mg/dL. Neonatal and breast feeding jaundice is mild, unconjugated hyperbilirubinemia between days 2-5 after birth with peak levels at 5-10mg/dL. They decline to normal concentrations within 2 weeks. The newborn is not jaundiced at birth. A rapidly rising unconjugated bilirubin level, or absolute levels >20mg/dL, puts the infant at risk for bilirubin encephalopathy, or kernicterus. Bilirubin crosses an immature BBB and precipitates in the basal ganglia and other areas of the brain resulting in neurological deficits to death. Treatment options include phototherapy and transfusion exchange. Primary hepatocellular process includes viral, alcoholic, autoimmune, drug-induced, and cirrhotic hepatitis, Wilsons disease, hemochromatosis, and hepatocellular carcinoma Intra or extrahepatic cholestasis is recurrent attacks of pruritis and jaundice with intermittent complete resolution. The episode begins with mild malaise and increased LFTs, followed rapidly by increased alkaline phosphatase and conjugated bilirubin and may last from several weeks to months. Considered benign problem because it doesnt lead to cirrhosis or end stage liver disease. d) 2 conditions that cause impaired excretion of conjugates total bilirubin levels are usually 2-5mg/dL. Both of these patients have benign asymptomatic jaundice typically in their 20s. Dubin-Johnson Syndrome is a mutation in the gene for the ATP pump with altered bilirubin excretion into the bile ducts. It is a benign, relatively rare disorder with low-grade, predominantly conjugated hyperbilirubinemia. A cardinal feature is accumulation in hepatic lysosomes of dark, coarsely granular pigment making the liver grossly black in appearance. The gallbladder is usually not visualized Rotors syndrome is a problem with the hepatic storage of bilirubin. There is no increased liver pigmentation. It is a benign, autosomal recessive disorder. In Rotors syndrome, the gallbladder is usually visualized on oral cholecystography in contrast to the non-visualization that is typical of DJS. Post-Hepatic Post-hepatic is predominantly an obstruction of bilirubin release via hepatic duct obstruction. Most likely due to gallstones, cancer, or pancreatitis. This will lead to obstructive jaundice, which will present with clay-colored stools. SEE CHART! Differential Diagnosis of Abdominal Pain Generalized Abdominal pain can be caused by gastritis, viral and infectious gastroenteritis, and irritable/inflammatory bowel syndrome. Other causes include: Ruptured viscus can be caused by peptic ulcer, appendicitis, or diverticulitis. Can lead to peritonitis. Suspect if there is positive rebound tenderness. Obstruction of the intestines via hernia, adhesion, paralytic ileus, intussusception, fecal impaction, carcinoma, or mesenteric infarction. Suspect if bowel sounds are hyperactive with ostipation and distention. Systemic Vascular anemia, CHF, coagulopathy, mesenteric embolus Inflammatory infectious peritonitis (TB, pneumococcal, gonococcal) Neoplasm leukemia, metastasis, GI carcinoma Autoimmune rheumatic fever, HSP, dermatomyositis Trauma paralytic ileus, hemoperitoneum Endocrine DKA, Addisonian crisis, electrolyte disturbance Tests NG tube CBC Urinalysis Abdominal x-ray CXR Amylase and Lipase Chem-7 Pregnancy test Specific Locations RUQ liver, GB, bile ducts, duodenum, colon, pancreatic head, right kidney Hepatitis Liver infarction Abscess or carcinoma Cholelithiasis Cholecystitis Cholangitis Peptic ulcer Diverticulitis Colitis Pancreatitis or carcinoma Pyelonephritis Nephrolithiasis LUQ spleen, stomach, colon, pancreas, adrenal, left kidney, aorta Ruptured or infracted spleen Infectious mononucleosis Leukemia/lymphoma Gastric ulcer Rupture or carcinoma Pyloric stenosis Hiatal hernia Gastroenteritis Diverticulitis Colitis Pancreatitis or carcinoma Pyelonephritis Nephrolithiasis Aortic aneurysm RLQ Ileum, cecum, appendix, ureters, fallopian tubes, ovaries Intussusception Mesenteric infarction Diverticulitis Colon carcinoma Gastroenteritis Diverticulum Impacted feces/constipation Appendicitis Nephrolithiasis Salpingitis Ovarian cyst or neoplasm Endometriosis Ectopic pregnancy Aortic aneurysm LLQ sigmoid colon, small intestine, ureter, fallopian tube, ovaries Intussusception Diverticulitis Volvulus Mesenteric ischemia Colon carcinoma Gastroenteritis Diverticulum Impacted feces/constipation Nephrolithiasis Salpingitis Ovarian cyst or neoplasm Endometriosis Ectopic pregnancy Aortic aneurysm Remember that injury or disease of the skin, fascia and bones (including the ribs and vertebrae) can cause pain Herpes zoster Contusion Cellulitis Rib fracture Hernia Herniated disc or spinal tumor Compression of nerve roots Peripheral neuropathies Osteoarthritis Differential Diagnosis of Nausea and Vomiting Top of GI tract: Nasopharynx tonsillitis, foreign body Esophagus aortic aneurysm, reflux, esophagitis, carcinoma, stricture, achlasia Stomach gastritis, ulcer, carcinoma, pyloric stenosis Small Intestine ulcers, enteritis, mesenteric ischemia, parasites, obstruction Appendix appendicitis, carcinoid tumor Colon ischemic or infectious colitis, carcinoma, diverticulum, ulcerative colitis Pertaining to accessory organs following conditions can cause N/V: Gallbladder cholecystitis, cholelithiasis, carcinoma Pancreas pancreatitis, pancreatic cyst or carcinoma Disease or injury to other organs or systems may also cause N/V: Kidney pyelonephritis, carcinoma, drug nephropathy, glomerulonephritis, nephrolithiasis Pelvic organs ovarian torsion, pelvic inflammatory disease, ectopic pregnancy Lungs - pneumonia Blood chronic anemia, leukemia, multiple myeloma, uremia #$%CDO ? S  Ugwx_`aTUVƾٹޱީީƢƖƖƊ hEhE hE6 hEhA hA6 hFChEhEhFC6hFChFC6 hE5hEhE5hE h`hFChFChFC5 hFC5hFCh` h`5 hA5>* h 5>* h 5>*4$%D ux`aUV^ 8VW'p & FgdE & FgdEgdE6V^'Qpk|>q~567Zdgtv;kluvz{Ѱ٨hK$h~h5hRlh~h5H* hRlH*hRlhRlh~h5hK$hK$hK$5h~hh~h6 h~hh~hha`hA>*ha`hA5>*h~hh~h5 h~h5 hE5h~hhEhE5 hEhEhE hA>*2pJA67ZZ[gd~h & Fgd~h & Fgd~h & Fgd~h^gd~h & FgdE{YZ[^jkIJK]^_ hjžۯۨ␕ hK$h~hh3hK$5 h35h3 h36 h~h6 hK$6 h~h56h~hh~h56 hb 6 hu&h~hhu& hA>*ha`hA>* hA6 h~hh~h h~h5h~hh~h6hK$h~hhK$h~h51J.:;Vt"%#$$l%'3(5(B(4)5)@)A)j)k)w))) **gd~h[_f-.EF9:;>VW! E ! !!;"s"t""""""""""# #"#$#%#G#H## $/$$$򬥠 h35 hz/phu& hz/p6hz/phz/p6 hz/p5 hu&5 h3hu&hz/phz/ph35h84h35h84h845h84 hu&6 hb 6hu&h~h h~h5 hK$h~hh3h35h3hK$ hK$52$$$k%l%m%%%M&&''''2(3(4(5(A(B(C(P(3)4)5)?)@)A)k)w)x))) **** *K*^*_*y*|*****;+<+G+Ŀ񶺮hA ho5hAh_(h.W ho56ho5ho5>* hA5>* hA6ho5ho55ho5 ho55 hA>*ha`hA>*hu&hu&5 hu&5hz/phz/p5 hz/p5hb hz/phb hz/p hb 6 hb 51***<+++++ ,;,o,,,,,,,,--- -/-0-C-D--- & Fgdo5 & Fgdo5G+++++++++ ,,:,F,n,v,,,,,,,.-/-D-G----G.H.L...//0002%363C3^3_3i3j33333333<4=4F4f4g4m44445ͺͳ h/F6 h/Fh5h5h55 h55>* h5h5 h56 ho5h5h5 hA>*ho5ho55 ho56ho5 ho55hA hA6 ho5ho5h/F>--------..).8.H.I........ //(/7/?/Y/h/ & F gd5 & Fgdo5h/x////////00,0H0U0e0q000000111!1*1>1 & F gd5 & F gd5gd5 & F gd5>1N1^1k111111111]2k2u222222222$3%36373_3 & F gd5gd5 & F gd5_3`33333=4>4g4h44455:5;5q5r55566_6`6r6s66gd55595:5C5p5q5r55555 666^6_6e6q6r6x666 h ^h5h ^h5h55h5h556 h/Fh5h/F h56,1h/ =!"#$% @@@ NormalCJ_HaJmH sH tH DA@D Default Paragraph FontRi@R  Table Normal4 l4a (k@(No List.X $%Dux` a U V ^ 8 V W   ' p J A67ZZ[J.:;Vt%l3 5 B 4!5!@!A!j!k!w!!! """"<##### $;$o$$$$$$$$%%% %/%0%C%D%%%%%%%%%%&&)&8&H&I&&&&&&&& ''('7'?'Y'h'x''''''''((,(H(U(e(q(((((()))!)*)>)N)^)k)))))))))]*k*u*********$+%+6+7+_+`+++++=,>,g,h,,,--:-;-q-r---.._.`.r.s..000000000000000000 0 0 0 00000 0 0 0 0 0000000 0 07 0700000 0 0 0 0000000000000000000000000000000000000 0 0 0 0 0 000 0 0 0 0 0 0 0 000000 0 0 0 0 0 0 0 0 0 0  0  0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00 0 0 0 0 0 0 0 0 000000000000000000000000000000000V{$G+56!#$&+p*-h/>1_36 "%'()*6YY|YSY|χY\Y2''>)>)h,h,.((C)C)m,m,.8*urn:schemas-microsoft-com:office:smarttagsCity9*urn:schemas-microsoft-com:office:smarttagsplace |4I...s..G#y###+++<,F,f,m,,-9-C-p-- ..^.e.q.x...... 5@ &mXMonC|tq]*$ D-fNlA2$y Ut<EGYS`Ld;ZfB/:qz%\y88^8`o() ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.88^8`o() ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.88^8`o() ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.88^8`o() ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.88^8`o()^`o()  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.88^8`o() ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.88^8`o() ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.88^8`o() ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.88^8`o() ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.^`o() ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.88^8`o() ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH.88^8`o() ^`hH.  L ^ `LhH.   ^ `hH. xx^x`hH. HLH^H`LhH. ^`hH. ^`hH. L^`LhH. Ld;ZEGYtq]*y UlAD-o5@ X\y/:q .LZ        :^        tH        d        H2r`       "                Cu        b                 V>        L0        M<b AK$u&_(o5/F ^a`~hz/p5Rl,0.W84`FC 3E@.. ...@UnknownGz Times New Roman5Symbol3& z Arial"h[F[Ff'T'T!r4..2QHX)? 2#GI Introduction to GI and BilirubinInformation TechnologyInformation Technology<         Oh+'0 8D d p |$GIIntroduction to GI and BilirubinInformation TechnologyNormalInformation Technology15Microsoft Office Word@?@О/@lo'՜.+,0  hp  St John's UniversityT.G $GIIntroduction to GI and Bilirubin Title  !"#$%&'()*+,./012346789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXZ[\]^_`bcdefghkRoot Entry F@rmData -1Table5FWordDocument.XSummaryInformation(YDocumentSummaryInformation8aCompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q